Table 1.

Observation time and the development of esophageal adenocarcinoma or its precursor lesions

n*Person-yearsMedian follow-up, y (range)No. events
Cancer3441,6375.4 (0.2-8.9)38
Aneuploidy3091,4675.5 (0.4-8.9)35
Tetraploidy3091,4315.3 (0.2-8.9)42
  • * Number of subjects without the outcome at baseline.